TrivarX Limited (MDBIF) Research

TrivarX Limited operates as a health technology enterprise, focusing on the creation of advanced, AI-driven, and scientifically validated instruments for the detection and diagnosis of behavioral health disorders. The company's reach extends across both Australia and the United States. Beyond its core diagnostic tools, TrivarX provides specialized mental well-being programs tailored for businesses as a corporate health solution, and also develops various products for the wider healthcare provider market. The firm, which was founded in 1987 and is headquartered in Mount Lawley, Australia, changed its name to TrivarX Limited in October 2023, having previously operated under the name Medibio Limited.

Market snapshot

Symbol
MDBIF
Price
$0.00
Day change
0.00%
Market cap
$26.5M
P/E ratio
-12.18x
52-week range
0.0025-0.02435
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Next earnings
in 2 months

Peer companies

  • AI/ML Innovations Inc. (AIMLF)
  • Comprehensive Healthcare Systems, Inc. (CMHSF)
  • Avem Health Partners, Inc. (FPCG)
  • Underwood Capital Limited (MMJJF)
  • Oxford BioDynamics Plc (OXBOF)
  • PreAxia Health Care Payment Systems Inc. (PAXH)
  • SpotLite360 IOT Solutions, Inc. (SPLTF)
  • Red Light Holland Corp. (TRUFF)

Open TrivarX Limited (MDBIF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.